← Open Payments lookup

DAVID HELSEL: Open Payments

NPI 1669463840 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 40 payments from 12 companies in 2025. Trend: 2023 $436 · 2024 $707 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc7$181
Otsuka America Pharmaceutical, Inc.8$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$122
E.R. Squibb & Sons, L.L.C.4$70
Lundbeck LLC3$56
Collegium Pharmaceutical, Inc.3$54
Alkermes, Inc.2$34
Teva Pharmaceuticals USA, Inc.2$31
Supernus Pharmaceuticals, Inc.1$17
Axsome Therapeutics, Inc.1$17

Products named: SPRAVATO, REXULTI, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, Jornay PM, LYBALVI, AUSTEDO XR.

Industry payments across PA — which companies pay providers there.